Cash flow Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe Other stock markets 08:43:05 09/12/2025 GMT			5-day change	1st Jan Change
130.60 ^GBX	+0.08%		+2.56%	+1.13%

12-08	Oxford Nanopore Technologies plc Announces Chief Executive Officer Changes, Effective March 2, 2026	CI
12-08	EXECUTIVE CHANGES: Oxford Nanopore Tech hires new CEO from Danaher	AN

ca3422ce06.ifle1_qLdm89HWNRDyLuBXX8SoI_7xhXNC0YaVCbkQc.y78YsIvHNSVfLQpoV2acMjulG-11tkkdAUtWDjHT4WPtyTDnjv4SKFlWKg

Published financial data: OXFORD NANOPORE TECHNOLOGIES PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	114M	134M	199M	170M	183M
Total Revenues	114M	134M	199M	170M	183M
Cost of Goods Sold, Total	66.98M	60.47M	74.79M	79.19M	77.8M
Gross Profit	46.88M	73.2M	124M	90.48M	105M
Selling General & Admin Expenses, Total	71.39M	162M	157M	155M	157M
R&D Expenses	48.55M	75.98M	64.84M	103M	98.47M
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-	-	-	889K	2.73M
Other Operating Expenses, Total	120M	238M	222M	259M	258M
Operating Income	-73.06M	-165M	-98.48M	-169M	-152M
Interest Expense, Total	-747K	-908K	-1.63M	-2.21M	-3.56M
Interest And Investment Income	91K	224K	5.94M	18.85M	14.84M
Net Interest Expenses	-656K	-684K	4.31M	16.65M	11.28M
Income (Loss) On Equity Invest.	-	-64K	-238K	-228K	-18K
Currency Exchange Gains (Loss)	-	504K	-5.43M	2.12M	-151K
Other Non Operating Income (Expenses)	563K	-	-	-	-
EBT, Excl. Unusual Items	-73.15M	-165M	-99.84M	-150M	-141M
Gain (Loss) On Sale Of Investments	-	-1.23M	-2.19M	297K	1.26M
Gain (Loss) On Sale Of Assets	-	-	18.62M	-	-
EBT, Incl. Unusual Items	-73.15M	-166M	-83.41M	-150M	-140M
Income Tax Expense	-11.91M	1.61M	7.61M	4.74M	6.23M
Earnings From Continuing Operations	-61.24M	-168M	-91.02M	-155M	-146M
Net Income to Company	-61.24M	-168M	-91.02M	-155M	-146M
Net Income - (IS)	-61.24M	-168M	-91.02M	-155M	-146M
Net Income to Common Incl Extra Items	-61.24M	-168M	-91.02M	-155M	-146M
Net Income to Common Excl. Extra Items	-61.24M	-168M	-91.02M	-155M	-146M
Per Share Items
Net EPS - Basic	-0.1	-0.23	-0.11	-0.19	-0.16
Basic EPS - Continuing Operations	-0.1	-0.23	-0.11	-0.19	-0.16
Basic Weighted Average Shares Outstanding	615M	732M	824M	834M	898M
Net EPS - Diluted	-0.1	-0.23	-0.11	-0.19	-0.16
Diluted EPS - Continuing Operations	-0.1	-0.23	-0.11	-0.19	-0.16
Diluted Weighted Average Shares Outstanding	615M	732M	824M	834M	898M
Normalized Basic EPS	-0.07	-0.14	-0.08	-0.11	-0.1
Normalized Diluted EPS	-0.07	-0.14	-0.08	-0.11	-0.1
American Depositary Receipts Ratio (ADR)	4	4	4	4	4
Supplemental Items
EBITDA	-62.94M	-152M	-82.46M	-150M	-139M
EBITA	-73.06M	-164M	-98.43M	-169M	-152M
EBIT	-73.06M	-165M	-98.48M	-169M	-152M
EBITDAR	-	-	-	-150M	-138M
Effective Tax Rate - (Ratio)	16.28	-0.97	-9.13	-3.16	-4.45
Total Current Taxes	-10.82M	6.16M	7.92M	4.52M	3.99M
Total Deferred Taxes	-1.09M	-4.56M	-310K	214K	2.24M
Normalized Net Income	-45.72M	-103M	-62.4M	-93.79M	-88.27M
Interest on Long-Term Debt	747K	908K	1.63M	2.2M	3.56M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	48.55M	75.98M	64.84M	104M	98.92M
Net Rental Expense, Total	-	-	-	928K	971K
Imputed Operating Lease Interest Expense	-	-	-	432K	632K
Imputed Operating Lease Depreciation	-	-	-	496K	339K
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	20.89M	-6.15M
Stock-Based Comp., Other (Total)	6.86M	62.45M	70.01M	14.02M	10.07M
Total Stock-Based Compensation	6.86M	62.45M	70.01M	34.91M	3.92M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	80.86M	488M	357M	221M	200M
Short Term Investments	-	-	119M	49.51M	139M
Total Cash And Short Term Investments	80.86M	488M	476M	270M	338M
Accounts Receivable, Total	50.89M	38.47M	41.18M	33.83M	37.54M
Other Receivables	24.91M	22.49M	20.2M	28.7M	31.81M
Total Receivables	75.8M	60.97M	61.38M	62.53M	69.35M
Inventory	35.63M	63.07M	87.7M	102M	99.45M
Prepaid Expenses	10.8M	8.1M	10.67M	12.8M	12.92M
Other Current Assets, Total	62K	131M	2.06M	261K	-
Total Current Assets	203M	751M	638M	447M	520M
Gross Property Plant And Equipment	88.82M	110M	127M	162M	192M
Accumulated Depreciation	-35.62M	-47.72M	-64.25M	-79.35M	-90.78M
Net Property Plant And Equipment	53.2M	61.92M	63.2M	82.42M	101M
Long-term Investments	548K	257K	84.97M	209M	74.31M
Other Intangibles, Total	446K	396K	30.04M	2.14M	43.82M
Deferred Tax Assets Long-Term	1.44M	6.08M	7.68M	5.49M	2.64M
Deferred Charges Long-Term	22.42M	22.61M	-	30.77M	-
Total Assets	281M	842M	824M	777M	742M
Liabilities
Accounts Payable, Total	31.01M	20.49M	23.1M	25.18M	31.3M
Accrued Expenses, Total	20.74M	55.11M	41.32M	43.87M	54.02M
Current Portion of Leases	2.04M	2.61M	15.05M	4.32M	5.36M
Current Income Taxes Payable	570K	4.42M	1.64M	-	-
Unearned Revenue Current, Total	17.83M	21.63M	20.3M	15.16M	20.67M
Other Current Liabilities	-	789K	1.12M	671K	145K
Total Current Liabilities	72.18M	105M	103M	89.2M	111M
Long-Term Debt	9.5M	9.5M	-	-	-
Long-Term Leases	12.09M	12.69M	19.05M	37.33M	40.61M
Other Non Current Liabilities	1.5M	10.65M	8.75M	6.68M	3.62M
Total Liabilities	95.28M	138M	130M	133M	156M
Common Stock, Total	36K	82K	83K	86K	96K
Additional Paid In Capital	611M	624M	628M	699M	780M
Retained Earnings	-459M	-15.9M	-106M	-258M	-402M
Comprehensive Income and Other	34.38M	96.04M	172M	203M	209M
Total Common Equity	186M	704M	694M	644M	586M
Total Equity	186M	704M	694M	644M	586M
Total Liabilities And Equity	281M	842M	824M	777M	742M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	649M	822M	826M	859M	955M
ECS Total Common Shares Outstanding	649M	822M	826M	859M	955M
Book Value / Share	0.29	0.86	0.84	0.75	0.61
Tangible Book Value	185M	704M	664M	642M	543M
Tangible Book Value Per Share	0.29	0.86	0.8	0.75	0.57
Total Debt	23.63M	24.8M	34.1M	41.66M	45.96M
Net Debt	-57.23M	-463M	-442M	-228M	-292M
Debt Equivalent Oper. Leases	-	-	-	7.42M	7.77M
Equity Method Investments, Total	548K	257K	826K	742K	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	11.74M	25.78M	41.85M	50.89M	37.63M
Inventories - Work In Process, Total	14.36M	17.83M	34.96M	39.15M	45.64M
Inventories - Finished Goods, Total	9.53M	19.46M	10.89M	11.51M	16.18M
Land - (BS)	16.4M	15.06M	-	-	-
Machinery, Total	27.75M	33.32M	38.86M	48M	55.22M
Full Time Employees	527	803	1.01K	1.24K	1.38K
Assets on Operating Lease - Gross	20M	30.08M	39.84M	54.76M	62.06M
Assets on Operating Lease - Accumulated Depreciation	-11.49M	-15.87M	-23.5M	-27.13M	-27.4M
Accumulated Allowance for Doubtful Accounts (Supple)	1.96M	2.96M	2.61M	947K	2.08M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-61.24M	-168M	-91.02M	-155M	-146M
Depreciation & Amortization - CF	12.5M	15.55M	20.44M	23.14M	19.33M
Amortization of Goodwill and Intangible Assets - (CF)	-	50K	50K	72K	256K
Depreciation & Amortization, Total	12.5M	15.6M	20.49M	23.21M	19.58M
Amortization of Deferred Charges, Total - (CF)	4.84M	9.09M	11.38M	18.42M	23.7M
(Gain) Loss From Sale Of Asset	1K	837K	-16.74M	3.85M	7.51M
(Gain) Loss on Sale of Investments - (CF)	-	1.23M	2.19M	-144K	724K
Asset Writedown & Restructuring Costs	-	-	1.17M	-	-
(Income) Loss On Equity Investments - (CF)	-	64K	238K	228K	18K
Stock-Based Compensation (CF)	6.86M	62.45M	48.78M	34.91M	3.92M
Other Operating Activities, Total	-3.34M	7.5M	1.8M	-21.83M	-17.32M
Change In Accounts Receivable	-41.48M	10.89M	-7.4M	118K	-1.82M
Change In Inventories	-15.59M	-27.44M	-24.72M	-43.06M	-21.18M
Change In Accounts Payable	33.66M	33.57M	4.43M	1.5M	21.17M
Cash from Operations	-63.81M	-53.83M	-49.39M	-137M	-110M
Capital Expenditure	-15.74M	-21.54M	-23.07M	-5.91M	-13.94M
Sale of Property, Plant, and Equipment	-	-	42.5M	-	-
Sale (Purchase) of Intangible assets	-10.74M	-9.28M	-19.16M	-21.38M	-34.69M
Investment in Marketable and Equity Securities, Total	-548K	-131M	-69.5M	-48.4M	54.16M
Other Investing Activities, Total	81K	207K	3.44M	13.9M	9.51M
Cash from Investing	-26.94M	-162M	-65.79M	-61.79M	15.03M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.06M	-2.36M	-13.61M	-4.29M	-4.68M
Total Debt Repaid	-2.06M	-2.36M	-13.61M	-4.29M	-4.68M
Issuance of Common Stock	164M	642M	3.75M	71.6M	83.23M
Other Financing Activities, Total	-3.32M	-16.88M	-3.86M	-2.57M	-4.97M
Cash from Financing	159M	623M	-13.72M	64.73M	73.58M
Foreign Exchange Rate Adjustments	-61K	-117K	-2.17M	-1.88M	258K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	67.77M	407M	-131M	-136M	-21.02M
Supplemental Items
Cash Interest Paid	644K	949K	1.48M	2.21M	2.64M
Cash Income Tax Paid (Refund)	-7.3M	-8.8M	-1.23M	417K	-4.21M
Levered Free Cash Flow	-43.85M	-155M	-47.54M	-75.44M	-82.2M
Unlevered Free Cash Flow	-43.38M	-155M	-46.53M	-74.06M	-79.98M
Change In Net Working Capital	-4.55M	108M	44.62M	17.93M	-16.66M
Net Debt Issued / Repaid	-2.06M	-2.36M	-13.61M	-4.29M	-4.68M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-20.48	-18.31	-7.39	-13.16	-12.53
Return on Total Capital	-27.01	-21.92	-8.45	-14.91	-14.45
Return On Equity %	-41.46	-37.67	-13.03	-23.11	-23.77
Return on Common Equity	-41.46	-37.67	-13.03	-23.11	-23.77
Margin Analysis
Gross Profit Margin %	41.17	54.76	62.34	53.33	57.53
SG&A Margin	62.7	121.02	79.28	91.33	85.45
EBITDA Margin %	-55.27	-113.42	-41.52	-88.66	-75.67
EBITA Margin %	-64.17	-123.06	-49.56	-99.33	-83.02
EBIT Margin %	-64.17	-123.1	-49.59	-99.38	-83.16
Income From Continuing Operations Margin %	-53.79	-125.4	-45.83	-91.06	-79.8
Net Income Margin %	-53.79	-125.4	-45.83	-91.06	-79.8
Net Avail. For Common Margin %	-53.79	-125.4	-45.83	-91.06	-79.8
Normalized Net Income Margin	-40.16	-77.05	-31.42	-55.28	-48.18
Levered Free Cash Flow Margin	-38.51	-116.16	-23.94	-44.46	-44.87
Unlevered Free Cash Flow Margin	-38.1	-115.74	-23.43	-43.65	-43.66
Asset Turnover
Asset Turnover	0.51	0.24	0.24	0.21	0.24
Fixed Assets Turnover	2.36	2.32	3.17	2.33	2
Receivables Turnover (Average Receivables)	3.5	2.99	4.99	4.52	5.13
Inventory Turnover (Average Inventory)	2.41	1.23	0.99	0.84	0.77
Short Term Liquidity
Current Ratio	2.81	7.15	6.22	5.01	4.66
Quick Ratio	2.17	5.22	5.24	3.73	3.66
Operating Cash Flow to Current Liabilities	-0.88	-0.51	-0.48	-1.54	-0.99
Days Sales Outstanding (Average Receivables)	104.5	122.02	73.2	80.68	71.29
Days Outstanding Inventory (Average Inventory)	152.07	297.89	367.89	436.15	472.82
Average Days Payable Outstanding	95.21	106.9	80.01	94.72	136.54
Cash Conversion Cycle (Average Days)	161.37	313.01	361.07	422.11	407.56
Long Term Solvency
Total Debt/Equity	12.71	3.52	4.92	6.47	7.84
Total Debt / Total Capital	11.28	3.4	4.69	6.08	7.27
LT Debt/Equity	11.61	3.15	2.75	5.8	6.93
Long-Term Debt / Total Capital	10.3	3.05	2.62	5.45	6.42
Total Liabilities / Total Assets	33.88	16.38	15.82	17.14	20.98
EBIT / Interest Expense	-97.8	-181.2	-60.49	-76.43	-42.73
EBITDA / Interest Expense	-81.07	-164.03	-47.9	-65.91	-37.24
(EBITDA - Capex) / Interest Expense	-102.14	-187.74	-62.07	-68.59	-41.15
Total Debt / EBITDA	-0.39	-0.17	-0.44	-0.29	-0.35
Net Debt / EBITDA	0.95	3.11	5.67	1.57	2.2
Total Debt / (EBITDA - Capex)	-0.31	-0.15	-0.34	-0.28	-0.31
Net Debt / (EBITDA - Capex)	0.75	2.72	4.37	1.51	1.99
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	118.7	17.39	48.59	-14.57	7.97
Gross Profit, 1 Yr. Growth %	82.99	56.14	69.15	-26.92	16.48
EBITDA, 1 Yr. Growth %	-9.8	140.87	-45.6	82.43	-7.85
EBITA, 1 Yr. Growth %	-9.68	125.13	-40.16	71.23	-9.77
EBIT, 1 Yr. Growth %	-9.68	125.2	-40.15	71.21	-9.65
Earnings From Cont. Operations, 1 Yr. Growth %	-15.19	173.68	-45.69	69.74	-5.38
Net Income, 1 Yr. Growth %	-15.19	173.68	-45.69	69.74	-5.38
Normalized Net Income, 1 Yr. Growth %	-9.11	125.25	-39.41	50.31	-5.89
Diluted EPS Before Extra, 1 Yr. Growth %	-19.71	163.73	-51.75	67.66	-12.11
Accounts Receivable, 1 Yr. Growth %	260.29	-24.41	7.04	-17.85	10.96
Inventory, 1 Yr. Growth %	77.83	77.03	39.05	15.79	-2.06
Net Property, Plant and Equip., 1 Yr. Growth %	22.71	16.39	2.07	30.4	22.78
Total Assets, 1 Yr. Growth %	70.7	199.37	-2.14	-5.68	-4.51
Tangible Book Value, 1 Yr. Growth %	69.35	279.31	-2.56	-7.43	-11.2
Common Equity, 1 Yr. Growth %	69.76	278.62	-1.48	-7.17	-8.93
Cash From Operations, 1 Yr. Growth %	31.08	-15.64	-7.17	115.12	-19.97
Capital Expenditures, 1 Yr. Growth %	-14.76	36.85	7.13	-31.58	136.08
Levered Free Cash Flow, 1 Yr. Growth %	-49.01	254.08	93.01	38.86	8.96
Unlevered Free Cash Flow, 1 Yr. Growth %	-49.33	256.58	93.33	38.93	7.98
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	87.11	60.23	32.07	12.67	-3.96
Gross Profit, 2 Yr. CAGR %	71.09	69.03	62.51	11.18	-7.74
EBITDA, 2 Yr. CAGR %	5.45	47.4	14.47	-0.38	29.66
EBITA, 2 Yr. CAGR %	7.91	42.6	16.07	1.22	24.3
EBIT, 2 Yr. CAGR %	7.91	42.62	16.1	1.23	24.37
Earnings From Cont. Operations, 2 Yr. CAGR %	7.38	52.35	21.91	-3.99	26.73
Net Income, 2 Yr. CAGR %	7.38	52.35	21.91	-3.99	26.73
Normalized Net Income, 2 Yr. CAGR %	8.6	43.08	16.82	-4.57	18.93
Diluted EPS Before Extra, 2 Yr. CAGR %	4.55	35.83	12.81	-10.05	21.39
Accounts Receivable, 2 Yr. CAGR %	109.69	65.03	-10.05	-6.23	-4.53
Inventory, 2 Yr. CAGR %	38.39	77.43	56.89	26.89	6.49
Net Property, Plant and Equip., 2 Yr. CAGR %	41.79	19.51	8.99	15.37	26.53
Total Assets, 2 Yr. CAGR %	26.7	126.06	71.17	-3.93	-5.1
Tangible Book Value, 2 Yr. CAGR %	13.93	153.45	89.13	-2.93	-11.53
Common Equity, 2 Yr. CAGR %	14.07	153.52	93.14	-4.37	-8.05
Cash From Operations, 2 Yr. CAGR %	6.67	5.15	-12.02	60.64	31.21
Capital Expenditures, 2 Yr. CAGR %	18.62	8	21.08	-47.63	27.09
Levered Free Cash Flow, 2 Yr. CAGR %	-14.32	34.37	4.13	75.01	23.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	-14.59	34.42	3.56	75.43	22.48
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	102.13	60.18	56.25	14.22	11.08
Gross Profit, 3 Yr. CAGR %	91.02	65.95	69.07	24.51	12.92
EBITDA, 3 Yr. CAGR %	-0.61	38.87	5.73	33.71	-2.94
EBITA, 3 Yr. CAGR %	3.5	37.88	6.76	32.13	-2.58
EBIT, 3 Yr. CAGR %	3.5	37.9	6.78	32.15	-2.54
Earnings From Cont. Operations, 3 Yr. CAGR %	2.7	46.67	8.02	36.13	-4.46
Net Income, 3 Yr. CAGR %	2.7	46.67	8.02	36.13	-4.46
Normalized Net Income, 3 Yr. CAGR %	3.56	38.5	7.45	27.06	-5.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.56	35.93	-3.8	28.74	-10.74
Accounts Receivable, 3 Yr. CAGR %	124.55	49.24	42.85	-12.73	-0.82
Inventory, 3 Yr. CAGR %	76.78	50.23	63.58	41.79	16.39
Net Property, Plant and Equip., 3 Yr. CAGR %	35.52	32.76	13.39	15.71	17.79
Total Assets, 3 Yr. CAGR %	33.08	68.75	71.01	40.33	-4.12
Tangible Book Value, 3 Yr. CAGR %	25.61	70.12	82.3	51.24	-7.3
Common Equity, 3 Yr. CAGR %	25.71	70.16	85.01	51.29	-5.91
Cash From Operations, 3 Yr. CAGR %	-1.29	-1.36	0.48	29.1	27.35
Capital Expenditures, 3 Yr. CAGR %	-7.25	24.41	7.71	-27.87	-13.49
Levered Free Cash Flow, 3 Yr. CAGR %	-4.68	37.49	-17.93	19.83	49.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-5.01	37.53	-18.4	19.52	49.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	173.35	96.79	70.49	39.15	28.61
Gross Profit, 5 Yr. CAGR %	203.52	157.62	79.06	41.39	32.69
EBITDA, 5 Yr. CAGR %	7.81	18.97	5.17	21.59	14.72
EBITA, 5 Yr. CAGR %	10.57	20.42	8.36	21.85	13.46
EBIT, 5 Yr. CAGR %	10.57	20.43	8.37	21.86	13.5
Earnings From Cont. Operations, 5 Yr. CAGR %	9.72	23.18	9.99	23.81	15.15
Net Income, 5 Yr. CAGR %	9.72	23.18	9.99	23.81	15.15
Normalized Net Income, 5 Yr. CAGR %	10.87	20.56	8.67	19.33	11.9
Diluted EPS Before Extra, 5 Yr. CAGR %	4.92	15.88	1.13	15.23	5.58
Accounts Receivable, 5 Yr. CAGR %	-	94.28	55.74	23.92	21.59
Inventory, 5 Yr. CAGR %	338.4	184.23	68.54	40.42	37.77
Net Property, Plant and Equip., 5 Yr. CAGR %	94.89	77.93	24.21	25.51	18.47
Total Assets, 5 Yr. CAGR %	20.92	39.57	47.18	34.71	35.12
Tangible Book Value, 5 Yr. CAGR %	13.22	37.29	47.96	35.04	37.71
Common Equity, 5 Yr. CAGR %	13.27	37.31	49.27	35.13	39.87
Cash From Operations, 5 Yr. CAGR %	14	1	-5.73	19.61	17.68
Capital Expenditures, 5 Yr. CAGR %	74.88	48.01	3.18	-11.99	-5.46
Levered Free Cash Flow, 5 Yr. CAGR %	13.55	22.91	-1.25	4.78	-0.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.31	22.82	-1.67	4.49	-1.35